Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia
Sponsor: Tanta University
Summary
Androgenetic alopecia (AGA) is a common form of hair loss characterized by progressive hair follicle miniaturization. This prospective randomized comparative study evaluates the efficacy and safety of intradermal exosome injections compared with 5% topical minoxidil in patients with AGA. Forty patients were randomly assigned to receive either intradermal exosome injections or topical minoxidil for three months, with clinical, trichoscopic, patient-reported, and safety outcomes assessed at baseline, after treatment, and at 3-month follow-up.
Official title: A Prospective, Randomized, Comparative Study of the Efficacy and Safety of Intradermal Exosome Injections Versus Topical Minoxidil in Patients With Androgenetic Alopecia
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-04-20
Completion Date
2025-12-31
Last Updated
2026-08-20
Healthy Volunteers
No
Conditions
Interventions
exosomes injection
intradermal injections of 1 mL of Exomide
Topical Minoxidil 5%
5% topical minoxidil solution
Locations (1)
Tanta University Hospitals
Tanta, Egypt